Journal
CHEMICAL COMMUNICATIONS
Volume 56, Issue 24, Pages 3567-3570Publisher
ROYAL SOC CHEMISTRY
DOI: 10.1039/c9cc09849f
Keywords
-
Categories
Funding
- National Institutes of Health [NIH NS103873, AG10124, AG062418]
- Michael J. Fox Foundation
- National Science Foundation [NSF CHE-1827457, NIH RR-023444, NSF MRI-0820996]
- NSF [DGE-1321851]
- Parkinson's Disease Foundation [PF-RVSA-SFW-1754]
- Age-Related Neurodegenerative Disease Training Grant fellowship [NIH T32AG000255]
Ask authors/readers for more resources
Fluorescent small molecules are powerful tools for imaging alpha-synuclein pathology in vitro and in vivo. In this work, we explore benzofuranone as a potential scaffold for the design of fluorescent alpha-synuclein probes. These compounds have high affinity for alpha-synuclein, show fluorescent turn-on upon binding to fibrils, and display different binding to Lewy bodies, Lewy neurites and glial cytoplasmic inclusion pathologies in post-mortem brain tissue. These studies not only reveal the potential of benzofuranone compounds as alpha-synuclein specific fluorescent probes, but also have implications for the ways in which alpha-synucleinopathies are conformationally different and display distinct small molecule binding sites.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available